vs
Side-by-side financial comparison of HARROW, INC. (HROW) and INSEEGO CORP. (INSG). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $48.4M, roughly 1.8× INSEEGO CORP.). HARROW, INC. runs the higher net margin — 7.4% vs 1.0%, a 6.5% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 0.6%). INSEEGO CORP. produced more free cash flow last quarter ($11.6M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 13.6%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
HROW vs INSG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $48.4M |
| Net Profit | $6.6M | $469.0K |
| Gross Margin | 79.3% | 42.2% |
| Operating Margin | 17.5% | 2.7% |
| Net Margin | 7.4% | 1.0% |
| Revenue YoY | 33.3% | 0.6% |
| Net Profit YoY | -2.2% | 182.9% |
| EPS (diluted) | $0.20 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $48.4M | ||
| Q3 25 | $71.6M | $45.9M | ||
| Q2 25 | $63.7M | $40.2M | ||
| Q1 25 | $47.8M | $31.7M | ||
| Q4 24 | $66.8M | $48.1M | ||
| Q3 24 | $49.3M | $54.0M | ||
| Q2 24 | $48.9M | $51.6M | ||
| Q1 24 | $34.6M | $37.5M |
| Q4 25 | $6.6M | $469.0K | ||
| Q3 25 | $1.0M | $1.4M | ||
| Q2 25 | $5.0M | $507.0K | ||
| Q1 25 | $-17.8M | $-1.6M | ||
| Q4 24 | $6.8M | $-566.0K | ||
| Q3 24 | $-4.2M | $9.0M | ||
| Q2 24 | $-6.5M | $624.0K | ||
| Q1 24 | $-13.6M | $-4.5M |
| Q4 25 | 79.3% | 42.2% | ||
| Q3 25 | 75.3% | 41.6% | ||
| Q2 25 | 74.5% | 41.1% | ||
| Q1 25 | 67.5% | 47.3% | ||
| Q4 24 | 78.8% | 37.3% | ||
| Q3 24 | 75.6% | 34.8% | ||
| Q2 24 | 74.4% | 36.4% | ||
| Q1 24 | 69.5% | 35.3% |
| Q4 25 | 17.5% | 2.7% | ||
| Q3 25 | 20.6% | 4.7% | ||
| Q2 25 | 17.9% | 3.2% | ||
| Q1 25 | -23.5% | -1.3% | ||
| Q4 24 | 19.3% | 3.7% | ||
| Q3 24 | 2.7% | 1.9% | ||
| Q2 24 | 3.1% | 3.6% | ||
| Q1 24 | -20.0% | -7.9% |
| Q4 25 | 7.4% | 1.0% | ||
| Q3 25 | 1.4% | 3.1% | ||
| Q2 25 | 7.8% | 1.3% | ||
| Q1 25 | -37.2% | -5.0% | ||
| Q4 24 | 10.1% | -1.2% | ||
| Q3 24 | -8.6% | 16.6% | ||
| Q2 24 | -13.2% | 1.2% | ||
| Q1 24 | -39.2% | -11.9% |
| Q4 25 | $0.20 | $-0.02 | ||
| Q3 25 | $0.03 | $0.03 | ||
| Q2 25 | $0.13 | $-0.03 | ||
| Q1 25 | $-0.50 | $-0.16 | ||
| Q4 24 | $0.19 | $0.62 | ||
| Q3 24 | $-0.12 | $-0.06 | ||
| Q2 24 | $-0.18 | $-0.02 | ||
| Q1 24 | $-0.38 | $-0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $24.9M |
| Total DebtLower is stronger | $250.0M | — |
| Stockholders' EquityBook value | $52.4M | $-4.0M |
| Total Assets | $399.5M | $93.8M |
| Debt / EquityLower = less leverage | 4.77× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $24.9M | ||
| Q3 25 | $74.3M | $14.6M | ||
| Q2 25 | $53.0M | $13.2M | ||
| Q1 25 | $66.7M | $35.1M | ||
| Q4 24 | $47.2M | $39.6M | ||
| Q3 24 | $72.6M | $12.0M | ||
| Q2 24 | $71.0M | $49.0M | ||
| Q1 24 | $76.0M | $12.3M |
| Q4 25 | $250.0M | — | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | — | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — | ||
| Q1 24 | $243.4M | — |
| Q4 25 | $52.4M | $-4.0M | ||
| Q3 25 | $47.0M | $-7.7M | ||
| Q2 25 | $49.7M | $-10.5M | ||
| Q1 25 | $56.5M | $-13.0M | ||
| Q4 24 | $69.7M | $-12.9M | ||
| Q3 24 | $58.0M | $-85.1M | ||
| Q2 24 | $58.5M | $-101.8M | ||
| Q1 24 | $60.6M | $-105.6M |
| Q4 25 | $399.5M | $93.8M | ||
| Q3 25 | $363.1M | $85.8M | ||
| Q2 25 | $345.0M | $83.1M | ||
| Q1 25 | $364.2M | $93.0M | ||
| Q4 24 | $389.0M | $100.0M | ||
| Q3 24 | $351.5M | $113.4M | ||
| Q2 24 | $306.6M | $149.6M | ||
| Q1 24 | $295.5M | $122.1M |
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — | ||
| Q1 24 | 4.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $12.0M |
| Free Cash FlowOCF − Capex | $8.1M | $11.6M |
| FCF MarginFCF / Revenue | 9.1% | 24.0% |
| Capex IntensityCapex / Revenue | 0.4% | 0.7% |
| Cash ConversionOCF / Net Profit | 1.27× | 25.50× |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $12.0M | ||
| Q3 25 | $16.6M | $3.2M | ||
| Q2 25 | $-803.0K | $-4.5M | ||
| Q1 25 | $19.7M | $-3.5M | ||
| Q4 24 | $-17.8M | $-14.2M | ||
| Q3 24 | $3.0M | $14.8M | ||
| Q2 24 | $-2.7M | $27.6M | ||
| Q1 24 | $-4.6M | $5.2M |
| Q4 25 | $8.1M | $11.6M | ||
| Q3 25 | $16.4M | $3.1M | ||
| Q2 25 | $-969.0K | $-4.7M | ||
| Q1 25 | $19.5M | $-3.5M | ||
| Q4 24 | $-18.3M | $-14.3M | ||
| Q3 24 | $2.3M | $14.8M | ||
| Q2 24 | $-3.1M | $27.6M | ||
| Q1 24 | $-4.7M | — |
| Q4 25 | 9.1% | 24.0% | ||
| Q3 25 | 22.9% | 6.7% | ||
| Q2 25 | -1.5% | -11.6% | ||
| Q1 25 | 40.8% | -11.0% | ||
| Q4 24 | -27.4% | -29.7% | ||
| Q3 24 | 4.8% | 27.4% | ||
| Q2 24 | -6.3% | 53.5% | ||
| Q1 24 | -13.6% | — |
| Q4 25 | 0.4% | 0.7% | ||
| Q3 25 | 0.3% | 0.2% | ||
| Q2 25 | 0.3% | 0.5% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 0.8% | 0.1% | ||
| Q3 24 | 1.2% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.3% | 0.0% |
| Q4 25 | 1.27× | 25.50× | ||
| Q3 25 | 16.26× | 2.22× | ||
| Q2 25 | -0.16× | -8.81× | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.62× | — | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | — | 44.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
